Daily users had 40% higher odds of heart disease compared to non-users (aOR=1.40; 95% CI: 1.11, 1.76). A clear dose-response relationship was observed.
GLP-1 Weight Loss Pill FDA Warns of Cardiovascular Risks
GLP-1 Clinical Relevance #52Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. โ GLP-1 News | CED Clinic NewsObservationalObesityGLP-1 Receptor AgonistCardiologyAdults with ObesityCardiovascular OutcomesAppetite RegulationFDA Safety AlertWeight Loss PillDrug Safety...
GLP-1 Receptor Agonist Evidence: Weight Loss & Marriage Risk
GLP-1 Clinical Relevance #48Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. โ GLP-1 News | CED Clinic GLP-1 Relationship EffectsWeight Loss Divorce RiskOzempic Social ConsequencesMetabolic Therapy Marriage ImpactGLP-1 Psychosocial...
Cannabis Use in Older Surgical Patients: What Anesthesiologists Need to Know
The prevalence of cannabis use almost tripled over the past decade among older surgical patientsโa population already at higher risk of perioperative complicationsโyet evidence linking use to adverse outcomes remains equivocal and mostly limited to retrospective cohort studies.
Nationwide outcomes of cardiac surgery in patients with cannabis use disorder.
To characterize in-hospital morbidity and mortality in patients undergoing cardiovascular surgery with and without cannabis use disorder (CUD) using a nation…